Cita APA

Hirata, F., Ishiyama, K., Tanaka, Y., Kobayashi, T., Hashimoto, M., Saeki, Y., . . . Ohdan, H. (2018). Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis. Ann Gastroenterol Surg.

Chicago Style Citation

Hirata, Fumihiro, et al. "Effect of Bevacizumab Plus XELOX (CapeOX) Chemotherapy On Liver Natural Killer Cell Activity in Colorectal Cancer With Resectable Liver Metastasis." Ann Gastroenterol Surg 2018.

Cita MLA

Hirata, Fumihiro, et al. "Effect of Bevacizumab Plus XELOX (CapeOX) Chemotherapy On Liver Natural Killer Cell Activity in Colorectal Cancer With Resectable Liver Metastasis." Ann Gastroenterol Surg 2018.